Celcuity Newsroom

Celcuity Price Target Announced at $27.00/Share by LifeSci Capital

Dow JonesAug 26 22:56

Celcuity Analyst Ratings

BenzingaAug 26 22:47

LifeSci Capital Initiates Coverage on Celcuity With Outperform Rating, $27 Price Target

MT NewswiresAug 26 22:22

A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $23 to $39

Futu NewsAug 16 21:00

A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $23 to $39

Futu NewsAug 15 21:01

Celcuity Price Target Maintained With a $27.00/Share by HC Wainwright & Co.

Dow JonesAug 15 20:05

Celcuity Analyst Ratings

BenzingaAug 15 18:34

Needham Reiterates Buy on Celcuity, Maintains $23 Price Target

BenzingaAug 15 18:34

Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)

TipRanksAug 15 18:33

Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating

Futu NewsAug 14 20:33

Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating

Futu NewsAug 13 21:31

Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), Celcuity (CELC) and Intuitive Surgical (ISRG)

TipRanksJul 22 18:41

Celcuity Analyst Ratings

BenzingaJul 22 18:33

Leerink Partners Initiates Celcuity(CELC.US) With Buy Rating, Announces Target Price $29

Futu NewsJul 22 18:31

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Celcuity (CELC) and Icon (ICLR)

TipRanksMay 31 20:24

Celcuity Analyst Ratings

BenzingaMay 31 20:10

Celcuity Inc: Needham cuts price target from $24.00 to $23.00

Zhitong FinanceMay 31 20:04

Stifel Maintains Buy on Celcuity, Maintains $40 Price Target

BenzingaMay 17 01:50

Craig-Hallum: Assuming a Celcuity (CELC.US) buy rating, the target price was adjusted from $25.00 to $27.00.

Zhitong FinanceMay 16 23:40

Craig-Hallum Assumes Celcuity at Buy, Raises Price Target to $27

BenzingaMay 16 23:40